Literature DB >> 11432636

Coronary spasm induced by capecitabine.

B Schnetzler, N Popova, C Collao Lamb, A P Sappino.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432636     DOI: 10.1023/a:1011152931300

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  14 in total

Review 1.  Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1.

Authors:  Hui-Ming Chang; Rohit Moudgil; Tiziano Scarabelli; Tochukwu M Okwuosa; Edward T H Yeh
Journal:  J Am Coll Cardiol       Date:  2017-11-14       Impact factor: 24.094

2.  Capecitabine-induced cardiotoxicity mimicking myocardial infarction.

Authors:  T Sentürk; O Kanat; T Evrensel; A Aydinlar
Journal:  Neth Heart J       Date:  2009-08       Impact factor: 2.380

3.  Acute chest pain in a patient treated with capecitabine.

Authors:  C Camaro; P W Danse; H A Bosker
Journal:  Neth Heart J       Date:  2009-08       Impact factor: 2.380

4.  A case of capecitabine-induced coronary microspasm in a patient with rectal cancer.

Authors:  Leire Arbea; Isabel Coma-Canella; Rafael Martinez-Monge; Jesús García-Foncillas
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

5.  Recurrence location after resection of colorectal liver metastases influences prognosis.

Authors:  K M Govaert; C S van Kessel; E J A Steller; B L Emmink; I Q Molenaar; O Kranenburg; R van Hillegersberg; I H M Borel Rinkes
Journal:  J Gastrointest Surg       Date:  2014-01-29       Impact factor: 3.452

6.  Acute coronary artery thrombosis and vasospasm following capecitabine in conjunction with oxaliplatin treatment for cancer.

Authors:  Omar Dzaye; Suzy Cleator; Petros Nihoyannopoulos
Journal:  BMJ Case Rep       Date:  2014-09-22

7.  A phase I trial of bortezomib in combination with epirubicin, carboplatin and capecitabine (ECarboX) in advanced oesophagogastric adenocarcinoma.

Authors:  R C Turkington; C Purcell; C R James; J Millar; E Napier; D Law; R Gallagher; M Morris; R H Wilson; M M Eatock
Journal:  Invest New Drugs       Date:  2013-05-11       Impact factor: 3.850

8.  Acute coronary syndrome induced by oral capecitabine.

Authors:  Daniela Cardinale; Alessandro Colombo; Nicola Colombo
Journal:  Can J Cardiol       Date:  2006-03-01       Impact factor: 5.223

9.  Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second- or third-line treatment in patients with relapsed ovarian cancer: a phase I/II trial.

Authors:  C Rothermundt; R Hubner; T Ahmad; I Gibbens; C Keyzor; T Habeshaw; S Kaye; M Gore
Journal:  Br J Cancer       Date:  2006-01-16       Impact factor: 7.640

Review 10.  Vascular toxic effects of cancer therapies.

Authors:  Joerg Herrmann
Journal:  Nat Rev Cardiol       Date:  2020-03-26       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.